BioNTech CEO Ugur Sahin: "Our vaccine will likely work for mutated coronavirus variants" | DW News

 

“Even though this new variant has multiple mutations, only one percent of this protein is changed. And that means 99 percent are still the same,” Biontech CEO Ugur Sahin told DW. He said his company needed two weeks to determine whether the vaccine can inactivate it.